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ABSTRACT 
 
Infections of Hepatitis B and C viruses among seropositive Human immunodeficiency virus patients 
are a growing public health problem in Sub Saharan Africa characterized by unaffordable 
treatment, severe morbidity and associated mortality. This study was aimed at evaluating the 
seroprevalence of Hepatitis B and C viruses among HIV infected patients accessing health care at 
Federal Medical Centre, Keffi, Nigeria. The cross-sectional study took place between May-July 
2016. A total of 200 blood samples were collected from HIV patients after informed consent and 
self-administered questionnaires were completed. The samples were centrifuged and the serum 
screened for HBV and HCV using the immunochromatographic technique. A general prevalence of 
infection with hepatitis B and C viruses in the study population was 17.5%. The prevalence of HBV 
infection was 12.5% while HCV was 5.0%. Females have higher infection rates for both viruses (p 
> 0.05). HBV infection was highest among those aged 20-29 years (14.3%) and lowest among 
those aged 30-39 years (6.5%). HCV infection was highest among those aged > 40 years (8.7%) 
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and least among those aged 30-39 years (0.0%). Infection rates with blood transfusion, smoking 
habit, scarification marks and alcohol intake as risk factors were more for HBV than HCV (p > 
0.05). The HIV/HBV and HIV/HCV coinfection prevalence of 12.5% and 5.0% respectively is a 
cause for concern. This finding underscores the urgent need for more proactive HBV immunization 
programs and screening of HIV patients for HBV and HCV before and even during antiretroviral 
therapy. Health education against these silent killers should also be advocated. 
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1. INTRODUCTION 
 
Human immunodeficiency Virus (HIV), Hepatitis 
B virus (HBV), and Hepatitis C virus (HCV), are 
the three most common chronic viral infections 
all over the world [1]. They share similar 
transmission routes including sexual, blood-blood 
contact, and injecting drug usage [1,2]. Co-
infection with HIV and HCV and/or HBV is very 
common in certain populations, such as 
intravenous drug users (IDUs) who often            
share the contaminated needles/syringes for 
intravenous drug injection. It has been reported 
that the world prevalence of HIV-HCV co-
infection among IDUs can surpass 90% in certain 
populations [3]. 
 
Both hepatitis B virus and hepatitis C virus are 
equally endemic across Africa. The prevalence of 
mono-infection for hepatitis B infection in the 
general population in Nigeria ranges from 9%             
to 39%, and being above 7% considered 
hyperendemic [4]. HCV infection rate in Nigeria is 
also considerably high ranging from 5.8% to 
12.3% [4]. Due to the endemic nature of       
these viruses in the sub-Saharan region and           
the shared routes of transmission, co-infections 
of HIV-HBV or HIV-HCV or even HIV-HBV-HCV 
are not uncommon. Prevalence of co-infection 
varies depending on the population studied      
[5]. 
 
With the introduction of highly active retroviral 
therapy (HAART), more people are living longer. 
However, this gain is being threatened by the 
emerging challenges posed by co-morbidity with 
other viral infections like HBV and HCV and 
unfortunately while HBV is vaccine preventable, 
HCV is not yet [5]. 
 
Expert guidelines developed in the United States 
and Europe recommend screening of all HIV-
infected persons for infection with HCV and HBV 
and appropriate management of those found to 
be chronically infected [2]. In Nigeria, however, 
HIV-infected patients are not routinely screened 
for hepatitis viruses. Screening for HBV and HCV 
is only considered following observed deranged 
liver enzymes. Thus, there is no room for early 
detection of co-infections and institution of proper 
management of cases. Again, data on the 
prevalence of co-infection in our environment are 
still relatively scarce. This study is, therefore, 
aimed at evaluating the seroprevalence of 
Hepatitis B and C viruses in HIV infected patients 
accessing healthcare in Federal Medical Centre, 
Keffi, Nigeria. 
 
2. MATERIALS AND METHODS 
 
2.1 Study Area and Population 
 
The area of study for this research was Keffi. It is 
approximately 68 Km from Abuja, the Federal 
Capital Territory and 128 Km from Lafia, the 
capital of Nasarawa State. Keffi is located 
between latitude 8 5’N of the equator and 
longitude 7 8’E and situated on an altitude of 850 
M above sea level [6]. 
 
The study population was made up of 200 
consenting patients accessing ART clinic at 
Federal Medical Centre, Keffi, Nigeria who were 
randomly selected from both sexes. Socio-
demographic information of the confirmed HIV 
participant was obtained through oral interview. 
Such information included; age, sex, occupation 
and history of blood transfusion. 
 
2.2 Sample Collection 
 
About 5 ml of blood was collected from each 
confirmed HIV participant by venipuncture into a 
sterile plain universal container. The blood was 
allowed to clot for 30 minutes and centrifuged at 
3000 rpm for 5 minutes. A Pasteur pipette was 
used to harvest and dispense each serum into a 
new, labeled plain tube and stored at -20°C until 
ready for use. 
 
2.3 Ethical Approval 
 
Approval for this study was obtained from the 
Ethical Review Committee on Human Research, 
Federal Medical Centre, Keffi, Nigeria. 
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2.4 HBsAg Detection 
 
A rapid in vitro which is a qualitative                     
sandwich immunoassay diagnostic kit was                  
used to screen the sera for HBsAg. The                    
test kit (Healgen one step strips, Zhejiang                   
Orient Gene Biotech Ltd, China) utilizes a 
combination of monoclonal and polyclonal 
antibodies to detect HBsAg in serum. The test 
procedure and result interpretation were                
carried out according to the manufacturer’s 
instructions. 
 
2.5 Anti-HCV Detection 
 
A rapid in vitro diagnostic kit (HCV one step     
strip, Zhejiang Orient Gene Biotech Ltd,                   
China) was used for the detection of anti-HCV               
in serum. This kit uses recombinant proteins                
and synthesized peptides derived from core                  
and structural regions of HCV for the detection    
of anti-HCV in serum. The test procedure                    
and result interpretation were carried                            
out according to the manufacturer’s           
instructions. 
 
2.6 Statistical Analysis 
 
The data obtained were subjected to descriptive 
statistical analysis using SPSS version 17.0. 
 
Chi-square statistical test was used to                    
determine associations and values obtained 
were considered statistically significant at p≤ 
0.05. 
 
3. RESULTS 
 
Two hundred HIV infected patients were 
recruited for this study. Among them were 104 
(52.0%) males and 96 (48.0%) females. The 
overall prevalence of hepatitis in these HIV 
patients was 17.5%. Of these, 5.0% were 
reactive to anti-HCV and 12.5% to HBsAg. 
Females had higher infection rates for both 
viruses (p > 0.05). 
 
HBV infection was highest among those aged 
20-29 years (14.3%) and lowest among those 
aged 30-39 years (6.5%). For HCV infection, it 
was highest among those aged > 40 years 
(8.7%) and least among those aged 30-39 years 
(0.0%). Infection rates with blood transfusion, 
smoking habit, scarification marks, alcohol intake 
as risk factors were more for HBV than HCV (p > 
0.05). 
4. DISCUSSION 
 
With the increased access to antiretroviral 
therapy in resource limited settings, people living 
with HIV infection will continue to live longer. 
However, morbidity and mortality due to co-
infections with other viruses will increasingly 
become important. Although co infections with 
HBV and HCV among HIV positive patients is 
well documented in developing countries, the 
demographics and impact of these infections are 
not well defined in low resource countries like 
Nigeria. The need for new data on hepatitis 
coinfection to guide health policy on 
management of HIV coinfected patients is very 
important [7]. 
 
The prevalence of hepatitis carriage among HIV 
infected patients in this study was 17.5%. This is 
higher than findings of 15.5% in a similar study 
[8], 3.9% among patients [9] in Nigeria, 13.9% in 
Kano [10], 0.6% in Benin [2]. 
HBsAg the seromarker used for the detection in 
this study was found in 12.5% of the HIV infected 
patients. This prevalence was lower than findings 
of 15.5% in Benin [2], but higher than findings of 
3.0% in Lafia [5], 7.9% in Abuja [11], 3.9% in 
Lagos [9] and 12.3% in Kano [10] among HIV 
patients. Similar studies from other countries 
found 30.9% in Cote d’voire [12], 6.0% in Kenya 
[7] 1.16% in Pakistan [13], 10.3% in Brazil [1]. 
These differences in prevalence might be as a 
result of geographical location, population and 
sensitivity of tests used for screening. 
 
Similarly, the HCV/HIV coinfection in the present 
study was 5.0% i.e more than 2 times less than 
that of HBV among these patients. This is higher 
than reports of 1.6% in Kano [10], 2.3% in Abuja 
[11] but lower than 7.0% in Benin [2], 14.7% in 
Lagos [9]. Similar studies from other countries 
recorded 4.6% in Brazil [1], 10.3% in Kenya [7] 
and 1.42% in Pakistan among pregnant women 
[13]. The high prevalence recorded in the study 
especially with no obvious efficient risk factor as 
reported by other researchers might be 
connected with the fact that the transmission 
efficiency is determined by the amount of virus in 
a body fluid and the type and extent of the 
contact [14]. Unfortunately unlike HBV, HCV 
does not have vaccine yet. 
 
On the whole, the prevalence of HIV/HBV and 
HIV/HCV in these HIV patients might be a 
reflection of the viral prevalence in the 
community and thus risk factors is same for 
every member of the community. 
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Table 1. Prevalence of Hepatitis B and C viruses among HIV Infected patients accessing 
healthcare in Federal Medical Centre, Keffi, Nigeria with respect to some demographic 
variables 
 
Risk factors No. examined                           No. positive 
HBV (%) p value HCV (%) p value 
Gender 
Male 
Female 
 
104 
96 
 
12(11.5) 
13 (13.5) 
 
0.7059 
 
 
4(3.8) 
6(6.3) 
 
0.4587 
 
Age (Years) 
10-19 
20-29 
30-39 
>40 
 
29 
56 
46 
69 
 
7 (24.1) 
8 (14.3) 
3 (6.5) 
7 (10.1) 
 
 
0.2437 
 
 
2 (6.9) 
2 (3.6) 
0 (0.0) 
6 (8.7) 
 
 
0.2167 
 
Marital status 
Single 
Married 
Divorced 
 
91 
98 
11 
 
15 (16.5) 
8 (8.2) 
2 (18.2) 
 
 
0.2731 
 
 
3 (3.3) 
6 (6.1) 
1 (9.1) 
 
 
0.5823 
 
Occupation 
Students 
Farmers 
Unemployed 
Artisans 
Civil servants 
 
40 
57 
39 
45 
19 
 
10 (25.0) 
5 (8.2) 
1 (2.6) 
6 (13.3) 
3 (15.8) 
 
 
 
0.1011 
 
 
 
1 (2.5) 
1 (1.8) 
4 (10.3) 
2 (4.4) 
2 (10.5) 
 
 
 
0.3195 
 
 
Educational level 
Primary 
Secondary 
Tertiary 
 
14 
95 
91 
 
4 (28.6) 
13 (13.7) 
8 (8.8) 
 
 
0.1954 
 
0 (0.0) 
2 (15.4) 
8 (8.8) 
 
 
0.0970 
Scarification marks 
Tribal marks 
Tattoo 
No Scarification mark 
 
20 
7 
173 
 
3(15.0) 
0 (0.0) 
22 (12.7) 
 
0.6163 
 
0 (0.0) 
1 (14.3) 
9 (5.2) 
 
0.3552 
 
 
Smoking habit 
Yes 
No 
 
8 
192 
 
0(0.0) 
25 (13.0) 
 
0.3085 
 
 
1 (12.5) 
9 (4.7) 
 
0.3605 
 
History of blood transfusion 
Yes 
No 
 
49 
151 
 
3 (6.1) 
22 (14.6) 
 
0.1621 
 
 
2 (4.1) 
8 (5.3) 
 
0.7460 
 
Locality 
Rural 
Urban 
 
121 
79 
 
20 (16.5) 
5 (6.3) 
 
0.0573 
 
3 (2.5) 
7 (8.9) 
 
0.0555 
History of alcohol intake 
Yes 
No 
 
77 
123 
 
12 (15.6) 
13 (10.6) 
 
0.3597 
 
 
3 (3.9) 
7 (5.7) 
 
0.5890 
 
 
Gender was not found to be associated with the 
viral prevalence although both infections were 
higher among females than males (P > 0.05). 
This was contrary to observation reported from a 
study in Brazil [1] and in Kenya [7]. However, a 
similar study in Kano reported HBV higher in 
males [10] and in Lagos [9]. This is connected to 
the fact that females are more promiscuous        
in the study area and also practice         
unprotected sex with their partner in a 
polygamous setting. 
 
The age stratification in this study shows no 
statistical significance with age in HBV and none 
in HCV prevalence. HBsAg was detected more 
among HIV patients that were below aged 19 
years old while anti-HCV was more among those 
aged above 40 years old. This might be 
suggestive that those in such age are more 
active and likely to engage in unprotected sex 
and are also not aware of immunization. This 
was also reported in a similar study in Kano    
[10]. 
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The infections were not associated with marital 
status (p > 0.05). It was highest in divorced for 
both virus. This might be unconnected that both 
viruses are mainly sexually transmitted and risky 
behavior is likely to have predisposed the 
divorcee to infection by the viruses. This was 
also reported in a similar study in Brazil [1]. 
 
With reference to occupation, students recorded 
the highest seroprevalence (25.0%) for HBV 
infection while HCV prevalence was highest 
(10.5%) among civil servants. There was no 
statistically significant association between the 
viral infections and occupation. In a related 
development, the viral seroprevalence was 
highest among those with the lowest level of 
education and lowest among those with a tertiary 
education for HBV infection while for HCV 
infection, it was highest in secondary education 
level and least in primary education participants 
(p > 0.05). Education has long been 
acknowledged to be of great value in our life. It 
helps in making useful decision and sourcing of 
information concerning health and healthy living. 
Flores et al., [1] also reported same outcome in 
his study. 
 
Scarification marks in HBV and HCV infections 
was highest among those with a tribal mark             
and tattoo mark respectively. There was no 
statistically significant difference between viral 
infections and scarification marks (p > 0.05). 
Such was also reported in a similar study in Cote 
d’voire [12]. There was no statistically significant 
association between locality and the viral 
infections (p > 0.05). It was higher in rural than 
urban for HBV infection and vice versa for HCV 
infection. It is similar to studies in Nasarawa state 
[8,15]. 
 
Smoking habit, history of blood transfusion and 
history of alcohol intake are not possible risk 
factors for hepatitis B and C viruses among the 
study population (p > 0.05). It was higher for 
HBsAg among those without a history of smoking 
habit, history of blood transfusion and a history of 
alcohol intake, while for anti-HCV, it was higher 
among those that smoke [12. 5%], those with no 
history of blood transfusion and those with no 
history of alcohol intake. Pennap et al. [16] in 
Nigeria, KouassiM’Bengue et al. [12] in Cote 
d’voire and Agyeman and Ofori-Asenso, [17] in 
Ghana reported same in a similar study. 
 
5. CONCLUSION 
 
The present study has shown a high burden of 
HBV (12.5%) and HCV (5.0%) among HIV 
infected patients in the study area. Gender, age, 
marital status, occupation, education level, 
scarification marks, smoking habit, history of 
blood transfusion, locality and history of alcohol 
intake were not possible risk factors for HBV                
and HCV infections. This finding underscores  
the urgent need for more proactive HBV 
immunization programs and screening of HIV 
patients for HBV and HCV before and even 
during antiretroviral therapy. Public awareness 
campaigns against the infections should be 
advocated. 
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